RxDoctor Payments Data

Srinivas Kaza, MD

Otolaryngology · Canandaigua, NYNPI 1679597652

Payments from drug & device makers

$4,134in general payments, 2019–2025

Across 36 payments — averaging $114.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$2K
  • Medtronic$1K
  • Intuitive Surgical$277
  • Smith+Nephew$218
  • Stryker$210
  • Optinose US, Inc.$136
  • plus $172 from 4 others

What the payments were for

  • Travel & lodging$1,60039%
  • Food & beverage$2,38958%
  • Entertainment$1454%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Aerin Medical Inc.15$1,936
Medtronic(2 entities)10$1,186
Intuitive Surgical2$277
Smith+Nephew2$218
Stryker2$210
Optinose US, Inc.1$136
ARS Pharmaceuticals Operations, Inc.1$125
Boston Scientific1$18
Sanofi1$17
Xoran Technologies LLC1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,134 in reported general payments places this provider in the 75th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York

Medicare billing

Part B allowed, 2024
$118,136
Medicare patients
255
Services billed
2,393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$44,641
Azelastine-FluticasoneAzelastine/Fluticasone48$7,296
Sodium ChlorideSodium Chloride Irrig Solution114$7,029
SynthroidLevothyroxine Sodium86$6,541
Mometasone Furoate92$5,824
Azelastine Hcl200$5,721
Ipratropium Bromide151$3,952
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth30$3,422
Levothyroxine Sodium270$2,887
SingulairMontelukast Sodium11$2,838
Levocetirizine Dihydrochloride194$2,047
Fluticasone Propionate122$1,752
Famotidine86$1,282
Montelukast Sodium118$965
Liothyronine Sodium33$923

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Canandaigua

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →